119 related articles for article (PubMed ID: 15608667)
1. Deficiency in the gap junction protein connexin32 alters p27Kip1 tumor suppression and MAPK activation in a tissue-specific manner.
King TJ; Gurley KE; Prunty J; Shin JL; Kemp CJ; Lampe PD
Oncogene; 2005 Mar; 24(10):1718-26. PubMed ID: 15608667
[TBL] [Abstract][Full Text] [Related]
2. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation.
King TJ; Lampe PD
Carcinogenesis; 2004 May; 25(5):669-80. PubMed ID: 14742325
[TBL] [Abstract][Full Text] [Related]
3. Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kip1-deficient mice.
King TJ; Lampe PD
Cell Commun Adhes; 2005; 12(5-6):293-305. PubMed ID: 16531324
[TBL] [Abstract][Full Text] [Related]
4. The gap junction protein connexin32 is a mouse lung tumor suppressor.
King TJ; Lampe PD
Cancer Res; 2004 Oct; 64(20):7191-6. PubMed ID: 15492231
[TBL] [Abstract][Full Text] [Related]
5. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.
Philipp-Staheli J; Kim KH; Payne SR; Gurley KE; Liggitt D; Longton G; Kemp CJ
Cancer Cell; 2002 May; 1(4):355-68. PubMed ID: 12086850
[TBL] [Abstract][Full Text] [Related]
6. Role of connexin32 and beta-catenin in tumor promotion in mouse liver.
Schwarz M; Wanke I; Wulbrand U; Moennikes O; Buchmann A
Toxicol Pathol; 2003; 31(1):99-102. PubMed ID: 12597453
[TBL] [Abstract][Full Text] [Related]
7. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
[TBL] [Abstract][Full Text] [Related]
8. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1 )after forced connexin expression in lung and liver carcinoma cells.
Koffler L; Roshong S; Kyu Park I; Cesen-Cummings K; Thompson DC; Dwyer-Nield LD; Rice P; Mamay C; Malkinson AM; Ruch RJ
J Cell Biochem; 2000 Sep; 79(3):347-54. PubMed ID: 10972973
[TBL] [Abstract][Full Text] [Related]
10. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32.
Temme A; Buchmann A; Gabriel HD; Nelles E; Schwarz M; Willecke K
Curr Biol; 1997 Sep; 7(9):713-6. PubMed ID: 9285723
[TBL] [Abstract][Full Text] [Related]
11. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
[TBL] [Abstract][Full Text] [Related]
15. The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains.
Moennikes O; Buchmann A; Ott T; Willecke1 K; Schwarz M
Carcinogenesis; 1999 Jul; 20(7):1379-82. PubMed ID: 10383916
[TBL] [Abstract][Full Text] [Related]
16. Morphologic and molecular analysis of estrogen-induced pituitary tumorigenesis in targeted disruption of transforming growth factor-beta receptor type II and/or p27 mice.
Ikeda H; Yoshimoto T; Shida N; Miyoshi I; Nakayama K; Nakayama K; Oshima M; Taketo MM
Endocrine; 2001 Oct; 16(1):55-65. PubMed ID: 11822828
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
[TBL] [Abstract][Full Text] [Related]
18. WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.
Moennikes O; Stahl S; Bannasch P; Buchmann A; Schwarz M
Carcinogenesis; 2003 Sep; 24(9):1561-5. PubMed ID: 12819187
[TBL] [Abstract][Full Text] [Related]
19. p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.
Fabris L; Berton S; Pellizzari I; Segatto I; D'Andrea S; Armenia J; Bomben R; Schiappacassi M; Gattei V; Philips MR; Vecchione A; Belletti B; Baldassarre G
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13916-21. PubMed ID: 26512117
[TBL] [Abstract][Full Text] [Related]
20. The gap junction protein connexin32 interacts with the Src homology 3/hook domain of discs large homolog 1.
Duffy HS; Iacobas I; Hotchkiss K; Hirst-Jensen BJ; Bosco A; Dandachi N; Dermietzel R; Sorgen PL; Spray DC
J Biol Chem; 2007 Mar; 282(13):9789-9796. PubMed ID: 17284442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
